Orrick’s Life Sciences License Readiness Tool is simple to use:
What does it do?
Insights
GET STARTED HERE
Learn more
Review recommended action items for potential next steps
Review your License Readiness Scorecard
Complete a questionnaire in less than 10 minutes
Orrick’s Life Sciences team welcomes a conversation with you about your assessment and how we can help.
Royalty Licensing Insurrection in Life Sciences
Life Sciences Collaboration Deals
a Mainstay of Biotech Industry – Here Are
the Tax Consequences
Life Sciences Snapshot
– Venture Funding and Tech Trends in AI in Drug Discovery – Q3 2023
License and collaboration agreements are a
mainstay of the biotechnology and medical
technology industries. For innovative biotechnology
and medical device companies, these transactions can
provide up-front license fees, ongoing funding, milestone
payments and royalties. They can also be some of the most
complex transactions that innovators will enter. Use our readiness
tool to evaluate some of the key considerations that innovators will
face before entering into a license and collaboration agreement, so
you can be ready.
GET IN TOUCH
David Schulman
GET IN TOUCH
Stephen Thau
Contacts
GET IN TOUCH
David Schulman
GET IN TOUCH
Stephen Thau
CONTACTS
Royalty Licensing Insurrection in Life Sciences
Life Sciences Collaboration Deals
a Mainstay of Biotech Industry – Here Are
the Tax Consequences
Life Sciences Snapshot
– A Quarterly Report
on Financing Trends: Venture Funding and Tech Trends in Supplements – Q2 2023
INSIGHTS
GET STARTED HERE
Orrick’s Life Sciences team welcomes a conversation with you about your assessment and how we can help.
Review your License Readiness Scorecard
Complete a questionnaire in less than 10 minutes
Orrick’s Life Sciences License Readiness Tool is simple to use:
WHAT DOES IT DO?
Learn more
License and collaboration agreements are a mainstay of the biotechnology and medical technology industries. For innovative biotechnology and medical device companies, these transactions can provide up-front license fees, ongoing funding, milestone payments and royalties. They can also be some of the most complex transactions that innovators will enter. Use our readiness tool to evaluate some of the key considerations that innovators will face before entering into a license and collaboration agreement, so you can be ready.
Orrick’s Life Sciences team welcomes a conversation with you about your assessment and how we can help.
